Navigation Links
New compounds may treat both alcohol and cigarette addictions
Date:11/3/2010

Researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time.

In a paper published in the November 3, 2010 issue of Neuropsychopharmacology, the researchers showed that alcohol consumption in rodents was significantly decreased by two compounds that target neuronal nicotinic acetylcholine receptor (nAChR) subtype 34*.

nAChRs are proteins found in the brain and broader central nervous system that mediate the effects of substances such as nicotine. Recent human genetic studies have shown that the genes encoding the 34* subtype are of significant importance for susceptibility to both alcohol and nicotine dependence.

"The problem has been translating these important genetic findings into more effective medications for people," said co-senior author Selena E. Bartlett, PhD, director of the Preclinical Development group at the Gallo Center. The lead author of the study is Susmita Chatterjee, PhD, of the Gallo Center.

The work was done in collaboration with scientists led by co-senior author Hans Rollema, PhD, in the Neuroscience Research Unit at Pfizer Inc.

One of the new compounds, CP-601932, has been shown in a clinical study to be safe in humans, notes Bartlett. She recommends a clinical study to evaluate the compound's efficacy and potential benefits in treating both alcohol and nicotine dependence.

The other compound is PF-4575180. Both were developed by Pfizer.

"Alcohol and nicotine addiction are often treated as separate disorders," Bartlett says, "despite the fact that 60 to 80 percent of heavy drinkers smoke tobacco. There are very few effective strategies for treating these disorders separately, let alone together. Our data suggest that by targeting specific nAChR subtype
'/>"/>

Contact: Jennifer O'Brien
jennifer.o'brien@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Compounds in non-stick cookware may be associated with elevated cholesterol in children and teens
2. Breast cancer cells regulate multiple genes in response to estrogen-like compounds
3. Concentration, timing and interactions are key when it comes to dietary compounds
4. New pyrimidine compounds may lead to improved treatments for childhood brain cancer
5. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
6. Breast cancer survivors often rate post-treatment breast appearance only fair
7. Half of Teens Treated for Depression Will Relapse: Study
8. Peptide being tested to treat atherosclerosis inhibits ovarian cancer growth
9. Race may influence uterine cancer recurrence, despite treatment
10. Scientists seek urgent treatment for fatal sleeping sickness
11. Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the ... , Purchasing an accidental death and dismemberment rider for ... of rider provides benefits if the insured dies in an ... form of life insurance. , AD&D is not expensive ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... Soledad O,Brien to be Master Of Ceremonies, ... Lupus, Fifth Annual Awards Gala, May 7, ... Patti La Belle will be the featured entertainer ... Senator Tom Harkin, (D-Iowa),Sheila C. Johnson, CEO of ...
... new perspective in the study of infectious disease. Normally, ... an organism and how it works within the human ... Environmental Microbiology, Dr Carla Pruzzo, Dr Luigi Vezzulli and ... its interaction with the environment and found that this ...
... aggressive growth plan in,effect for 2008, YoNaturals Inc., the ... in their expansion efforts with new,vending locations in the ... YoNaturals has maintained a strong,dedication toward changing the way ... thus far is in large part due to their ...
... samples from chronic alcoholics reveals changes that occur at ... a potential treatment target, according to researchers from Wake ... Clinical and Experimental Research, the scientists said that a ... signaling and development is found at higher levels in ...
... May 2 AMERIGROUP,Corporation (NYSE: AGP ) today ... of Stockholders on May 8., A live broadcast ... 2008 at,10:00 a.m. Eastern Time. To access the broadcast ... investors, page of the Company,s,Web site, http://www.amerigroupcorp.com . ...
... 55 arent seeking timely treatment for heart attack because they ... Hollywood script tightening in the chest, shortness of breath, ... the finding of researchers who presented their study at the ... and Outcomes Research (QCOR) in Cardiovascular Disease and Stroke. ...
Cached Medicine News:Health News:Grammy Award Winner Patti LaBelle Is Featured Entertainer at Lupus Foundation of America Awards Gala 2Health News:Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines 2Health News:Analysis of alcoholics' brains suggests treatment target 2Health News:Some women more likely to miss or ignore heart attack warning signs 2Health News:Some women more likely to miss or ignore heart attack warning signs 3
(Date:1/23/2015)... , Jan. 23, 2015 Research and Markets ( ... Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and ... Video communication has been the topic of fascination since ... United States and the Soviet Russia. Earlier even ...
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of ... D 2015 enrollment data shows that 81 percent of ... access and extra discounts at certain pharmacies. The findings ... "Preferred pharmacy plans are now the foundation of Medicare ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... Finalises Contract to Develop Prototype of the World,s First Ever... -- JERUSALEM, August 31, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up -- STOCKHOLM, August 31, 2010 ... ... ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Medicine Technology:Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 2Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 3Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 4Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 5Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 6Medisafe 1 Technologies Finalises Contract to Develop Prototype of the World's First Ever Medicinal Syringe-Locking Device 7CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 2CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 3CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 4CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 5CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 6CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 7CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 8CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up 9
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: